Toward predicting CYP2D6-mediated variable drug response from CYP2D6 gene sequencing data
M van der Lee, WG Allard, RHAM Vossen… - Science translational …, 2021 - science.org
Pharmacogenomics is a key component of personalized medicine that promises safer and
more effective drug treatment by individualizing drug choice and dose based on genetic …
more effective drug treatment by individualizing drug choice and dose based on genetic …
Toward predicting CYP2D6-mediated variable drug response from CYP2D6 gene sequencing data.
M van der Lee, WG Allard… - Science …, 2021 - search.ebscohost.com
A prescription for dosing prediction: The highly polymorphic enzyme cytochrome P450 2D6
(CYP2D6) processes about a quarter of clinically used drugs. However, its activity varies …
(CYP2D6) processes about a quarter of clinically used drugs. However, its activity varies …
Toward predicting CYP2D6-mediated variable drug response from CYP2D6 gene sequencing data
M van der Lee, WG Allard, RHAM Vossen… - Science Translational …, 2021 - research.tue.nl
Pharmacogenomics is a key component of personalized medicine that promises safer and
more effective drug treatment by individualizing drug choice and dose based on genetic …
more effective drug treatment by individualizing drug choice and dose based on genetic …
[PDF][PDF] Towards predicting CYP2D6-mediated variable drug response from CYP2D6 gene sequencing data
M van der Lee, WG Allard… - an der.(2022 …, 2021 - scholarlypublications …
Pharmacogenomics is a key component of personalized medicine. It promises a safer and
more effective drug treatment by individualizing the choice of drug and dose based on an …
more effective drug treatment by individualizing the choice of drug and dose based on an …
Toward predicting CYP2D6-mediated variable drug response from CYP2D6 gene sequencing data
M van der Lee, WG Allard… - Science …, 2021 - pubmed.ncbi.nlm.nih.gov
Pharmacogenomics is a key component of personalized medicine that promises safer and
more effective drug treatment by individualizing drug choice and dose based on genetic …
more effective drug treatment by individualizing drug choice and dose based on genetic …
Toward predicting CYP2D6-mediated variable drug response from CYP2D6 gene sequencing data.
M van der Lee, WG Allard, R Vossen… - Science Translational …, 2021 - europepmc.org
Pharmacogenomics is a key component of personalized medicine that promises safer and
more effective drug treatment by individualizing drug choice and dose based on genetic …
more effective drug treatment by individualizing drug choice and dose based on genetic …
[PDF][PDF] an der.(2022, anuar 19)
M Lee - from https://hdl. handle. net/1887/3250514 … - scholarlypublications …
Pharmacogenomics is a key component of personalized medicine. It promises a safer and
more effective drug treatment by individualizing the choice of drug and dose based on an …
more effective drug treatment by individualizing the choice of drug and dose based on an …